Clinical trial
Practicability and Acceptability of Stylomax® in Children
NCT00476385 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00476385 |
|---|---|
| Title | Practicability and Acceptability of Stylomax® in Children |
| Official title | Usability and Acceptability of Stylomax® in Growth Hormone Deficient Children. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | somatropine |
| Enrollment | 12 |
| Start date | Jun 1, 2003 |
| Primary completion | Dec 1, 2005 |
| First posted | May 22, 2007 |
| Last update posted | Feb 12, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: